Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rank in Stocks #40932
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Share Price
$0.15648068
Market Cap
$60.25K
Change (1 day)
6.98%
Change (1 year)
10.16%
Country
VG
Trade CRISM Therapeutics Corporation (CRTX)

Category

Price of CRTX with the market cap of B
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
CRTX
$0.15648068
Market Capitalization of CRISM Therapeutics Corporation(CRTX)
Market Cap: $60.25K
As of August 2026 CRISM Therapeutics Corporation has a market cap of $60.25K. This makes CRISM Therapeutics Corporation the world's 40932nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of CRISM Therapeutics Corporation from 2003 to 2026
CRTX compared with Top 5 Most Popular stocks
Price of CRTX Asset B Mkt. of B Results
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$14,206,592 $60.25K
$5.470T +9,078,815,039.14%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$11,602,782 $60.25K
$4.467T +7,414,833,714.83%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$10,842,562 $60.25K
$4.174T +6,929,009,933.07%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$9,610,590 $60.25K
$3.700T +6,141,710,453.42%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$7,413,877 $60.25K
$2.854T +4,737,886,493.77%